ReoPro (abciximab) to inhibit blood clotting

You'll hear more about using ReoPro (abciximab) to inhibit blood clotting.

This biotech drug came out earlier this year in the U.S. Lilly expects to market it soon in Canada as well.

ReoPro is for patients undergoing balloon help keep the coronary artery open.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote